HBM Holdings Limited

SEHK:2142 주식 보고서

시가총액: HK$938.2m

HBM Holdings 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Jingsong Wang

최고 경영자

US$1.6m

총 보상

CEO 급여 비율55.8%
CEO 임기8.3yrs
CEO 소유권8.4%
경영진 평균 재임 기간less than a year
이사회 평균 재임 기간4.3yrs

최근 관리 업데이트

Recent updates

Investors Still Aren't Entirely Convinced By HBM Holdings Limited's (HKG:2142) Revenues Despite 30% Price Jump

Oct 02
Investors Still Aren't Entirely Convinced By HBM Holdings Limited's (HKG:2142) Revenues Despite 30% Price Jump

Not Many Are Piling Into HBM Holdings Limited (HKG:2142) Just Yet

Jul 18
Not Many Are Piling Into HBM Holdings Limited (HKG:2142) Just Yet

HBM Holdings (HKG:2142) Seems To Use Debt Quite Sensibly

May 23
HBM Holdings (HKG:2142) Seems To Use Debt Quite Sensibly

Take Care Before Jumping Onto HBM Holdings Limited (HKG:2142) Even Though It's 28% Cheaper

Apr 12
Take Care Before Jumping Onto HBM Holdings Limited (HKG:2142) Even Though It's 28% Cheaper

HBM Holdings Limited (HKG:2142) Surges 25% Yet Its Low P/S Is No Reason For Excitement

Jan 01
HBM Holdings Limited (HKG:2142) Surges 25% Yet Its Low P/S Is No Reason For Excitement

We're Not Very Worried About HBM Holdings' (HKG:2142) Cash Burn Rate

Feb 08
We're Not Very Worried About HBM Holdings' (HKG:2142) Cash Burn Rate

HBM Holdings (HKG:2142) Is In A Strong Position To Grow Its Business

May 30
HBM Holdings (HKG:2142) Is In A Strong Position To Grow Its Business

Revenue Downgrade: Here's What Analysts Forecast For HBM Holdings Limited (HKG:2142)

Apr 07
Revenue Downgrade: Here's What Analysts Forecast For HBM Holdings Limited (HKG:2142)

Here's What Analysts Are Forecasting For HBM Holdings Limited (HKG:2142) After Its Full-Year Results

Mar 31
Here's What Analysts Are Forecasting For HBM Holdings Limited (HKG:2142) After Its Full-Year Results

What Type Of Shareholders Own The Most Number of HBM Holdings Limited (HKG:2142) Shares?

Mar 10
What Type Of Shareholders Own The Most Number of HBM Holdings Limited (HKG:2142) Shares?

CEO 보상 분석

Jingsong Wang 의 보수는 HBM Holdings 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2024n/an/a

US$21m

Mar 31 2024n/an/a

US$22m

Dec 31 2023US$2mUS$885k

US$23m

Sep 30 2023n/an/a

-US$19m

Jun 30 2023n/an/a

-US$61m

Mar 31 2023n/an/a

-US$99m

Dec 31 2022US$2mUS$781k

-US$137m

Sep 30 2022n/an/a

-US$143m

Jun 30 2022n/an/a

-US$149m

Mar 31 2022n/an/a

-US$144m

Dec 31 2021US$13mUS$13m

-US$138m

Sep 30 2021n/an/a

-US$224m

Jun 30 2021n/an/a

-US$310m

Mar 31 2021n/an/a

-US$303m

Dec 31 2020US$21mUS$654k

-US$296m

보상 대 시장: Jingsong 의 총 보상 ($USD 1.59M )은 Hong Kong 시장( $USD 232.62K ).

보상과 수익: Jingsong 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Jingsong Wang (59 yo)

8.3yrs

테뉴어

US$1,585,000

보상

Dr. Jingsong Wang M.D., Ph D., serves as Chairman of Board of Directors of HBM Alpha Therapeutics, Inc. He has been Chief Executive Officer of HBM Holdings Limited and Harbour BioMed Shanghai Co., Ltd. sin...

리더십 팀

이름위치테뉴어보상소유권
Jingsong Wang
Founderno dataUS$1.59m8.42%
HK$ 79.0m
Yiping Rong
Chief Scientific Officer & Executive Director1.9yrsUS$547.00k0.028%
HK$ 261.1k
Youchen Chen
VP and Head of Investor Relations & Corporate Developmentless than a year데이터 없음데이터 없음
Bruce Zhang
VP & Head of Legal Affairsno data데이터 없음데이터 없음
Peter Moesta
Member of Scientific Advisory Board & Chief CMC Advisorno data데이터 없음데이터 없음
Xiaolu Tao
Chief Development Officerno data데이터 없음데이터 없음
Steve Arkinstall
Chief Scientific Advisor1.4yrs데이터 없음데이터 없음
Ben Chih
Chief Scientific Officer of Neurosciences - Harbour BioMed USless than a year데이터 없음데이터 없음
Michael Lee
Senior VP & Head of Biometricsless than a year데이터 없음데이터 없음
Amy Jiang
VP, Chief of Staff & Head of Quality Departmentless than a year데이터 없음데이터 없음
Yuanqing Wei
VP & Head of Translational Developmentless than a year데이터 없음데이터 없음
Raymond Zheng
Chief Business Officerno data데이터 없음데이터 없음

0.3yrs

평균 재임 기간

50yo

평균 연령

경험이 풍부한 관리: 2142 의 관리팀은 경험 (평균 재직 기간 0.3 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.

이사회 구성원

이름위치테뉴어보상소유권
Jingsong Wang
Founder8.3yrsUS$1.59m8.42%
HK$ 79.0m
Yiping Rong
Chief Scientific Officer & Executive Director2.5yrsUS$547.00k0.028%
HK$ 261.1k
Peter Moesta
Member of Scientific Advisory Board & Chief CMC Advisorno data데이터 없음데이터 없음
Robert Kamen
Independent Non-Executive Director & Member of Scientific Advisory Board7.9yrsUS$50.00k0.36%
HK$ 3.4m
Albert R. Collinson
Independent Non-Executive Director1.3yrsUS$21.00k데이터 없음
Alexander A. Zukiwski
Member of Scientific Advisory Board2.5yrs데이터 없음데이터 없음
Xiaoping Ye
Independent Non-Executive Director4yrsUS$50.00k데이터 없음
Jon Marc Wigginton
Member of Scientific Advisory Board4.4yrs데이터 없음데이터 없음
Robert Kramer
Member of Scientific Advisory Board7.9yrs데이터 없음데이터 없음
Frank Grosveld
Member of Scientific Advisory Board7.9yrs데이터 없음데이터 없음
Weiwei Chen
Senior Business Adviser & Non-Executive Director4yrsUS$50.00k데이터 없음
Zhigang Tian
Member of Scientific Advisory Board4.3yrs데이터 없음데이터 없음

4.3yrs

평균 재임 기간

61.5yo

평균 연령

경험이 풍부한 이사회: 2142 의 이사회는 경험(평균 재직 기간 4.3 년)으로 간주됩니다.